Connor, Clark & Lunn Investment Management Ltd. Dr Reddys Laboratories LTD Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 305,639 shares of RDY stock, worth $4.03 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
305,639
Previous 155,481
96.58%
Holding current value
$4.03 Million
Previous $12.4 Million
60.93%
% of portfolio
0.02%
Previous 0.07%
Shares
27 transactions
Others Institutions Holding RDY
# of Institutions
265Shares Held
106MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$151 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$149 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$132 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$124 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$74 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.19B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...